Comparison of adverse event profiles of carfilzomib-, elotuzumab-, and ixazomib-based therapies combined with lenalidomide and dexamethasone in patients with multiple myeloma using VigiBase.
Saved in:
| Title: | Comparison of adverse event profiles of carfilzomib-, elotuzumab-, and ixazomib-based therapies combined with lenalidomide and dexamethasone in patients with multiple myeloma using VigiBase. |
|---|---|
| Authors: | Matsumoto J; Department of Personalised Medicine and Preventive Healthcare Sciences, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan; Department of Pharmacy, Okayama University Hospital, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan. Electronic address: matsumotoj@okayama-u.ac.jp., Takeda T; Department of Pharmacy, Okayama University Hospital, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan; Department of Education and Research Centre for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan. Electronic address: takeda-t@okayama-u.ac.jp., Sugimoto S; Department of Personalised Medicine and Preventive Healthcare Sciences, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan. Electronic address: p4o64sue@s.okayama-u.ac.jp., Sakai T; Department of Pharmacy, Okayama University Hospital, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan; Department of Clinical Pharmacology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan. Electronic address: t-sakai@okayama-u.ac.jp., Loyao BB; Department of Personalised Medicine and Preventive Healthcare Sciences, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan; Department of Pharmacy, School of Health Care Professions, University of San Carlos, Talamban, Cebu City, Cebu 6000, Philippines. Electronic address: pmu589iw@s.okayama-u.ac.jp., Higashionna T; Department of Pharmacy, Okayama University Hospital, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan. Electronic address: t.higashionna@cc.okayama-u.ac.jp., Hamano H; Department of Clinical Pharmacology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan; Department of Pharmacy, Medical Development Field, Okayama University, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan. Electronic address: hamano.hirofumi@okayama-u.ac.jp., See GLL; Department of Pharmacy, School of Health Care Professions, University of San Carlos, Talamban, Cebu City, Cebu 6000, Philippines. Electronic address: glsee@usc.edu.ph., Ariyoshi N; Department of Personalised Medicine and Preventive Healthcare Sciences, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan. Electronic address: ariyoshi-n@okayama-u.ac.jp., Zamami Y; Department of Clinical Pharmacology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan; Department of Pharmacy, Medical Development Field, Okayama University, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan. Electronic address: zamami-y@okayama-u.ac.jp. |
| Source: | Leukemia research [Leuk Res] 2026 Jul; Vol. 166, pp. 108236. Date of Electronic Publication: 2026 Apr 15. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Pergamon Press Country of Publication: England NLM ID: 7706787 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5835 (Electronic) Linking ISSN: 01452126 NLM ISO Abbreviation: Leuk Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42001677 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Comparison of adverse event profiles of carfilzomib-, elotuzumab-, and ixazomib-based therapies combined with lenalidomide and dexamethasone in patients with multiple myeloma using VigiBase. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Matsumoto+J%22">Matsumoto J</searchLink>; Department of Personalised Medicine and Preventive Healthcare Sciences, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan; Department of Pharmacy, Okayama University Hospital, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan. Electronic address: matsumotoj@okayama-u.ac.jp.<br /><searchLink fieldCode="AU" term="%22Takeda+T%22">Takeda T</searchLink>; Department of Pharmacy, Okayama University Hospital, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan; Department of Education and Research Centre for Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan. Electronic address: takeda-t@okayama-u.ac.jp.<br /><searchLink fieldCode="AU" term="%22Sugimoto+S%22">Sugimoto S</searchLink>; Department of Personalised Medicine and Preventive Healthcare Sciences, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan. Electronic address: p4o64sue@s.okayama-u.ac.jp.<br /><searchLink fieldCode="AU" term="%22Sakai+T%22">Sakai T</searchLink>; Department of Pharmacy, Okayama University Hospital, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan; Department of Clinical Pharmacology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan. Electronic address: t-sakai@okayama-u.ac.jp.<br /><searchLink fieldCode="AU" term="%22Loyao+BB%22">Loyao BB</searchLink>; Department of Personalised Medicine and Preventive Healthcare Sciences, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan; Department of Pharmacy, School of Health Care Professions, University of San Carlos, Talamban, Cebu City, Cebu 6000, Philippines. Electronic address: pmu589iw@s.okayama-u.ac.jp.<br /><searchLink fieldCode="AU" term="%22Higashionna+T%22">Higashionna T</searchLink>; Department of Pharmacy, Okayama University Hospital, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan. Electronic address: t.higashionna@cc.okayama-u.ac.jp.<br /><searchLink fieldCode="AU" term="%22Hamano+H%22">Hamano H</searchLink>; Department of Clinical Pharmacology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan; Department of Pharmacy, Medical Development Field, Okayama University, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan. Electronic address: hamano.hirofumi@okayama-u.ac.jp.<br /><searchLink fieldCode="AU" term="%22See+GLL%22">See GLL</searchLink>; Department of Pharmacy, School of Health Care Professions, University of San Carlos, Talamban, Cebu City, Cebu 6000, Philippines. Electronic address: glsee@usc.edu.ph.<br /><searchLink fieldCode="AU" term="%22Ariyoshi+N%22">Ariyoshi N</searchLink>; Department of Personalised Medicine and Preventive Healthcare Sciences, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan. Electronic address: ariyoshi-n@okayama-u.ac.jp.<br /><searchLink fieldCode="AU" term="%22Zamami+Y%22">Zamami Y</searchLink>; Department of Clinical Pharmacology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan; Department of Pharmacy, Medical Development Field, Okayama University, 2-5-1 Shikata, Kita-ku, Okayama 700-8558, Japan. Electronic address: zamami-y@okayama-u.ac.jp. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227706787%22">Leukemia research</searchLink> [Leuk Res] 2026 Jul; Vol. 166, pp. 108236. <i>Date of Electronic Publication: </i>2026 Apr 15. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Comparative Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Pergamon+Press%22">Pergamon Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7706787 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-5835 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201452126%22">01452126 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42001677 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.leukres.2026.108236 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 108236 Titles: – TitleFull: Comparison of adverse event profiles of carfilzomib-, elotuzumab-, and ixazomib-based therapies combined with lenalidomide and dexamethasone in patients with multiple myeloma using VigiBase. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Matsumoto J – PersonEntity: Name: NameFull: Takeda T – PersonEntity: Name: NameFull: Sugimoto S – PersonEntity: Name: NameFull: Sakai T – PersonEntity: Name: NameFull: Loyao BB – PersonEntity: Name: NameFull: Higashionna T – PersonEntity: Name: NameFull: Hamano H – PersonEntity: Name: NameFull: See GLL – PersonEntity: Name: NameFull: Ariyoshi N – PersonEntity: Name: NameFull: Zamami Y IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2026 Jul Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1873-5835 Numbering: – Type: volume Value: 166 Titles: – TitleFull: Leukemia research Type: main |
| ResultId | 1 |
